Extracorporeal Membrane Oxygenation Systems Market Trends and Forecast by 2032

The extracorporeal membrane oxygenation systems market is progressing steadily with a CAGR of 5% from 2022-2032, as per the extracorporeal membrane oxygenation systems market analysis by Future Market Insights (FMI).

Recent developments in extracorporeal membrane oxygenation systems market innovations such as miniaturization of ECMO components like hollow pumps, which are used in various surgeries, aids in the transportation of critically ill patients, thereby increasing the ECOM systems market size.

As per the ECOM systems market study, the rising use of ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.

The study finds that extracorporeal membrane oxygenation devices are used in life-threatening situations when other forms of supportive care have failed. Furthermore, the use of ECMO in various healthcare settings has increased significantly owing to its wide range of applications.

The adoption of ECMO procedures is being promoted by several government organizations. One of them is GOLD (Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims to raise awareness about COPD and its treatment, which includes the use of ECMO oxygen machine thereby positively influencing the ECMO systems adoption trends.

The sudden spike in COVID-19 cases, combined with an increase in the number of critically ill patients requiring additional life support, has pushed up demand for ECMO machines. For patients with severe acute respiratory distress syndrome, extracorporeal membrane oxygenation therapy has been the preferred treatment option.

An increasing number of supportive government policies and the rapid FDA approval of extracorporeal membrane oxygenation equipment for emergency use have significantly increased the ECOM systems market opportunities.

Browse More Details@ https://www.futuremarketinsights.com/reports/extracorporeal-membrane-oxygenation-machine-market

Moreover, several companies are scaling up ECOM systems’ market share by expanding their manufacturing capabilities to meet the rising demand for assistive technologies.

On account of the factors mentioned above, the ECOM systems market is predicted to muster a revenue of about US$ 673 Mn by 2026.

Competitive Landscape: Companies like Abbott Laboratories, Medtronic, Alung Technologies, and Terumo Corporation dominate the global market.

Key Segments

By Product:

  • ECMO Machines
    • Portable Devices
    • Static Devices
  • Software

By Service Type:

  • Application
  • Middleware
  • Infrastructure

By Component:

  • Pumps
  • Oxygenators
  • Controllers
  • Cannul
  • Assessories

By Modality:

  • Veno-Venous
  • Veno-Arterials
  • Arterio-Venous

By Patient Type:

  • Neonates
  • Pediatrics
  • Adults

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more